Physicians struggle with how to prescribe, manage and support patients using medical cannabis due to the limited clinical data and lack of clinical cannabis products. Patients struggle with inconsistent medical cannabis products, lack of support in navigating the wide variety of medical cannabis products, and an industry with little regulation. All cannabis products are not the same. Standardized CBTs (cannabinoid based therapeutic) could eliminate the barriers encountered by physicians, patients, and regulators.
Verda will be able to control for this variability in strains and create CBT products that selectively and consistently meet the needs of a specific disease. Any CBT product should be tested in clinical models and not simply sold to the public. By working with our partners, Verda will be able to test CBT products in multiple models to confirm clinical utility and safety and to produce safe, effective CBTs.
Interested in learning more? Click here to contact Verda Bio.